Skip to main content
Full access
New Research
Published Online: 1 November 2010

Problem-Solving Therapy and Supportive Therapy in Older Adults With Major Depression and Executive Dysfunction

Abstract

Objective:

The purpose of this study was to determine whether problem-solving therapy is an effective treatment in older patients with depression and executive dysfunction, a population likely to be resistant to antidepressant drugs.

Method:

Participants were adults age 60 and older with major depression and executive dysfunction. Problem-solving therapy was modified to be accessible to this population. Participants were randomly assigned to 12 weekly sessions of problem-solving therapy or supportive therapy and assessed at weeks 3, 6, 9, and 12.

Results:

Of the 653 individuals referred for this study, 221 met selection criteria and were enrolled in the study. Reduction of depressive symptom severity was comparable for the two treatment groups during the first 6 weeks of treatment, but at weeks 9 and 12 the problem-solving therapy group had a greater reduction in symptom severity, a greater response rate, and a greater remission rate than the supportive therapy group (response rates at week 9: 47.1% and 29.3%; at week 12:56.7% and 34.0%; remission rates at week 9: 37.9% and 21.7%; at week 12: 45.6% and 27.8%). Problem-solving therapy yielded one additional response or remission over supportive therapy for every 4.4–5.6 patients by the end of the trial.

Conclusions:

These results suggest that problem-solving therapy is effective in reducing depressive symptoms and leading to treatment response and remission in a considerable number of older patients with major depression and executive dysfunction. The clinical value of this finding is that problem-solving therapy may be a treatment alternative in an older patient population likely to be resistant to pharmacotherapy.

Formats available

You can view the full content in the following formats:

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 1391 - 1398
PubMed: 20516155

History

Received: 19 September 2009
Revision received: 17 December 2009
Accepted: 25 March 2010
Published online: 1 November 2010
Published in print: November 2010

Authors

Affiliations

Patricia A. Areán, Ph.D.
From the Department of Psychiatry, University of California, San Francisco, and the Department of Psychiatry, Weill Cornell Medical College, New York, N.Y.
Patrick Raue, Ph.D.
From the Department of Psychiatry, University of California, San Francisco, and the Department of Psychiatry, Weill Cornell Medical College, New York, N.Y.
R. Scott Mackin, Ph.D.
From the Department of Psychiatry, University of California, San Francisco, and the Department of Psychiatry, Weill Cornell Medical College, New York, N.Y.
Dora Kanellopoulos, B.S.
From the Department of Psychiatry, University of California, San Francisco, and the Department of Psychiatry, Weill Cornell Medical College, New York, N.Y.
Charles McCulloch, Ph.D.
From the Department of Psychiatry, University of California, San Francisco, and the Department of Psychiatry, Weill Cornell Medical College, New York, N.Y.
George S. Alexopoulos, M.D.
From the Department of Psychiatry, University of California, San Francisco, and the Department of Psychiatry, Weill Cornell Medical College, New York, N.Y.

Notes

Address correspondence and reprint requests to Dr. Areán, University of California, San Francisco, Department of Psychiatry, 401 Parnassus Ave., San Francisco, CA 94143; [email protected] (e-mail).

Funding Information

Dr. McCulloch has received research funding from Amgen for statistical methodology. Dr. Alexopoulos has received grant support from or served in a consulting or speaking capacity for Bristol-Myers Squibb, Cephalon, Forest, GlaxoSmithKline, Janssen, Lilly, Merck, Novartis, Pfizer, and Sanofi-Aventis and holds equity in Johnson & Johnson. All other authors report no financial relationships with commercial interests.Supported by NIMH grants R01 MH064099, R01 MH063982, K24 MH074717, and P30 MH085943 and the Sanchez Foundation.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Full Text

View Full Text

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share